M/i Homes (MHO) traded up 0.45 % during a 24 hours period ending at 09:47 PM Central Europe on Tuesday 27th. One M/i Homes stock can currently be bought for about USD 125.74 on popular exchanges. Current supply of M/i Homes stocks is 25.2 mn. M/i Homes has a current market capitalization of USD 3.1 bn and approximately USD 62.6 mn worth of M/i Homes was traded on exchanges in the last 24 hours. Since last month end, M/i Homes has traded -9.37 % down. Simple moving average of last 200 days is at USD 137.89. The highest price of past 52 weeks was recorded at USD 163.66 on 06/25/2026. 52 weeks low was at USD 113.4 on 10/22/2026.
Here is how related stocks have performed in the past 24 hours:
Diodes (DIOD) traded up 2.49 % and now trades at USD 88.09. Current market capitalisation for Diodes is USD 3.8 bn. Diodes has a current price to earnings ratio of 43.87.
Interparfums (IPAR) traded up 0.12 % and now trades at USD 115.19. Current market capitalisation for Interparfums is USD 3.7 bn. Interparfums has a current price to earnings ratio of 22.03.
Dorman Products (DORM) traded down -0.4 % and now trades at USD 124.5. Current market capitalisation for Dorman Products is USD 3.8 bn. Current price/earnings ratio for Dorman Products is 17.26. Dorman Products, Inc. reported its third‑quarter 2026 results on October 26, 2026, filing a Form 8‑K that incorporated a press release and a detailed financial summary. Net sales rose modestly from the same period in 2025, with growth spread across the company’s light‑duty, heavy‑duty and specialty‑vehicle segments. Gross margin slipped to just under forty percent, while selling, general and administrative expenses grew slightly as a share of sales. Operating income and net income both fell compared with the prior year, and diluted earnings per share declined by about twenty percent. The company generated strong operating cash flow and used a portion of that cash to repurchase common shares, bringing its year‑to‑date share repurchases to a record level. In light of the quarter’s performance and anticipated pricing actions in the fourth quarter, Dorman lowered its 2026 full‑year sales‑growth outlook to a narrow range of two to three percent and trimmed its diluted earnings guidance to roughly eight dollars per share. The company remains confident that its balance sheet and liquidity position will support its long‑term growth strategy.
Dolby Laboratories (DLB) traded up 0.37 % and now trades at USD 62.82. Dolby Laboratories has a market capitalisation of USD 3.7 bn. Dolby Laboratories has a current price to earnings ratio of 23.91.
Legend Biotech (LEGN) traded up 5.81 % and now trades at USD 21.56. Current market capitalisation for Legend Biotech is USD 3.7 bn. Legend Biotech, a biopharmaceutical company listed on the Nasdaq, is scheduled to appear as a speaker at the upcoming 8th Annual Healthcare Symposium hosted by Gabelli in partnership with Columbia Business School. The symposium, set for November 13 in New York, will address current trends in oncology, specialty drug access, and artificial intelligence in healthcare. Legend Biotech’s representative will participate in a session on oncology innovation, sharing insights on the company’s research and development initiatives. No further corporate announcements or financial updates from Legend Biotech were disclosed in the materials provided. The event is positioned to bring together industry leaders to discuss broader healthcare dynamics, with Legend Biotech’s involvement highlighting its engagement in the evolving oncology landscape.
About M/i Homes
M/I Homes, Inc. is a housebuilding company that operates in single-family homes across Ohio, Indiana, Florida, North Carolina, Virginia, and Maryland. The company went public on October 3rd, 1986, and is listed on the New York Stock Exchange.